Summary
Edwards Lifesciences Corporation (EW) filed an 8-K on May 17, 2005, reporting the stockholder approval of amendments to its Long-Term Stock Incentive Compensation Program. The key changes, approved by the Board on February 17, 2005, and subsequently by stockholders, aim to enhance the company's ability to attract and retain talent through equity-based compensation. These amendments primarily involve an increase in the number of shares available for issuance under the program and adjustments to the types and limits of awards that can be granted.
Key Highlights
- 1Stockholder approval of the amended and restated Long-Term Stock Incentive Compensation Program on May 12, 2005.
- 2Increase in the total number of common shares available for issuance under the program by 1,400,000, to a new total of 16,900,000 shares.
- 3Elimination of the company's ability to award performance shares and performance units.
- 4Increase in the maximum number of shares that can be issued as restricted stock or restricted stock units from 500,000 to 1,000,000 shares.
- 5Increase in the maximum number of restricted stock/units per participant per fiscal year from 50,000 to 200,000 shares.
- 6Expansion of performance criteria for restricted stock issuances to qualify as performance-based compensation under Section 162(m) of the Internal Revenue Code.
Frequently Asked Questions
The amendments were primarily designed to increase the number of shares available for incentive compensation, adjust the types of awards that can be granted, and ensure that certain compensation qualifies as performance-based under tax regulations, thereby enhancing the company's ability to attract and retain key employees.
The increase in shares available for the program represents potential dilution. Investors should consider the total number of shares outstanding and the rate at which new shares are issued under compensation plans when evaluating potential dilution.
The filing does not explicitly state the reason for eliminating performance shares and units. However, the focus has shifted to expanding the criteria for restricted stock to qualify as performance-based compensation, suggesting a strategic adjustment in how equity incentives are structured and managed.
Expanding these criteria allows the Compensation and Governance Committee more flexibility in setting performance targets for restricted stock. This is crucial for ensuring that the compensation qualifies as 'performance-based compensation' under Section 162(m) of the Internal Revenue Code, which can provide tax advantages to the company.